Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Harnessing Silicene-to-Silicic Acid Conversion for Organelle-Specific Silica Deposition in Tumor Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

KIF7 promotes the proliferation of clear cell renal cell carcinoma by activating the WNT/β-catenin signaling pathway.

Clinical and experimental medicine·2026

Same author

A clinically practical aging clock (physical clock) for healthy aging: development, validation, and application for health assessment and intervention.

Science China. Life sciences·2026

Same author

Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study.

Medicine·2026

Same author

Low-Value Care Following Hospital and Private Equity Acquisition in Primary Care.

Medical care research and review : MCRR·2026

Same author

Conversion-driven heterointerface reconfiguration enables fast ion migration in iron disulfide/sulfur-based positive electrodes for aqueous batteries.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Stimuli-Responsive "Cluster Bomb" for Programmed Tumor Therapy.

Qi Lei¹, Shi-Bo Wang¹, Jing-Jing Hu¹

¹Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry and ‡The Institute for Advanced Studies, Wuhan University , Wuhan 430072, China.

|July 8, 2017

Summary

This summary is machine-generated.

A novel nanoplatform, doxorubicin@mesoporous silica nanoparticle-tungsten disulfide quantum dots (DOX@MSN-WS2-HP), acts as a stimuli-responsive "cluster bomb" for enhanced tumor suppression. This system effectively targets tumors, penetrates deeply, and delivers dual therapy for significant antitumor effects.

Keywords:

photothermal therapy programmed therapy quantum dot tumor homing peptide tumor penetration

More Related Videos

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

Related Experiment Videos

Last Updated: Feb 27, 2026

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

Area of Science:

Biomedical Engineering
Nanotechnology
Materials Science

Background:

Developing targeted drug delivery systems is crucial for improving cancer therapy efficacy.
Stimuli-responsive nanomaterials offer precise drug release and enhanced therapeutic outcomes.
Mesoporous silica nanoparticles (MSN) and tungsten disulfide quantum dots (WS2-HP) are promising nanocarriers for cancer treatment.

Purpose of the Study:

To design and evaluate a stimuli-responsive nanoplatform for high-performance tumor suppression.
To utilize a tumor-homing peptide (tLyP-1) for enhanced tumor targeting and penetration.
To combine chemotherapy and photothermal therapy (PTT) for synergistic antitumor effects.

Main Methods:

Synthesized doxorubicin-loaded MSN capped with tLyP-1-modified WS2-HP (DOX@MSN-WS2-HP).
Utilized benzoic-imine bonds for stimuli-responsive drug release at pH 6.8.
Investigated the dual-drug delivery of DOX@MSN-NH2 and WS2-HP for chemotherapy and near-infrared (NIR)-light-triggered PTT.

Main Results:

The nanoplatform demonstrated effective homing and enhanced penetration into 4T1 tumors.
The benzoic-imine bonds facilitated rapid dissociation in the tumor microenvironment.
DOX@MSN-NH2 targeted surface tumor cells, while WS2-HP penetrated deeper for PTT, leading to significant tumor suppression.

Conclusions:

The DOX@MSN-WS2-HP nanoplatform functions as an effective stimuli-responsive
cluster bomb
for synergistic tumor suppression.
The combination of chemotherapy and PTT, facilitated by targeted delivery and stimuli-responsive release, shows great potential for clinical applications in cancer therapy.